Stockreport

American Heart Association (AHA) Scientific Sessions Highlights Report 2025: Market Opportunities Lie in Novel Therapeutics Like Semaglutide, VK2735, SHR-1918, BacNav, and Satralizumab [Ya...

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF Key market opportunities lie in novel therapeutics like Semaglutide, VK2735, SHR-1918, BacNav, and Satralizumab. Dublin, Dec. 22, 2025 (GLOBE NEWSWIRE) -- The "America [Read more]